These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23288489)

  • 21. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An
    Seidelmann SB; Vardeny O; Claggett B; Yu B; Shah AM; Ballantyne CM; Selvin E; MacRae CA; Boerwinkle E; Solomon SD
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28341776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery.
    St Peter JV; Hartley GG; Murakami MM; Apple FS
    Clin Chem; 2006 Apr; 52(4):680-5. PubMed ID: 16497939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial.
    Brune K; Katus HA; Moecks J; Spanuth E; Jaffe AS; Giannitsis E
    Clin Chem; 2008 Jul; 54(7):1149-57. PubMed ID: 18451314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.
    Prausmüller S; Resl M; Arfsten H; Spinka G; Wurm R; Neuhold S; Bartko PE; Goliasch G; Strunk G; Pavo N; Clodi M; Hülsmann M
    Cardiovasc Diabetol; 2021 Feb; 20(1):34. PubMed ID: 33530999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.
    Salo PP; Havulinna AS; Tukiainen T; Raitakari O; Lehtimäki T; Kähönen M; Kettunen J; Männikkö M; Eriksson JG; Jula A; Blankenberg S; Zeller T; Salomaa V; Kristiansson K; Perola M
    Circ Cardiovasc Genet; 2017 Dec; 10(6):e001713. PubMed ID: 29237677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes.
    Ellis KL; Newton-Cheh C; Wang TJ; Frampton CM; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Davis N; Yandle TG; Troughton RW; Richards AM; Cameron VA
    J Mol Cell Cardiol; 2011 Apr; 50(4):695-701. PubMed ID: 21276798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
    Huelsmann M; Neuhold S; Resl M; Strunk G; Brath H; Francesconi C; Adlbrecht C; Prager R; Luger A; Pacher R; Clodi M
    J Am Coll Cardiol; 2013 Oct; 62(15):1365-72. PubMed ID: 23810874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.
    Neuhold S; Resl M; Huelsmann M; Strunk G; Adlbrecht C; Rath C; Prager R; Luger A; Clodi M; Pacher R
    Eur J Clin Invest; 2011 Dec; 41(12):1292-8. PubMed ID: 21615391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bower JK; Lazo M; Matsushita K; Rubin J; Hoogeveen RC; Ballantyne CM; Selvin E
    Am J Hypertens; 2015 Oct; 28(10):1262-6. PubMed ID: 25783741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.